Weiss Multi-Strategy Advisers’s Clementia Pharmaceuticals Inc. CMTA Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio CMTA Stock Details CMTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-105,000	Closed	-$1.24M	–	659
2018 Q4	$1.24M	Sell	105,000 -52,500	-33%	-$653K	0.05%	278
2018 Q3	$1.76M	Buy	157,500 +4,499	+3%	+$47.3K	0.05%	342
2018 Q2	$2.01M	Sell	153,001 -26,999	-15%	-$437K	0.05%	342
2018 Q1	$2.73M	Sell	180,000 -10,000	-5%	-$163K	0.09%	274
2017 Q4	$3.61M	Sell	190,000 -152,256	-44%	-$2.55M	0.09%	246
2017 Q3	$5.78M	Buy	+342,256	New	+$5.59M	0.21%	138

Other funds holding CMTA

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

KLCMU

Kite Lake Capital Management (UK) London, United Kingdom $125M AUM 198.01% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Weiss Multi-Strategy Advisers's CMTA Position: Q1 2019 in Review

Weiss Multi-Strategy Advisers sold out of Clementia Pharmaceuticals Inc. (CMTA) in Q1 2019, closing a stake of 105,000 shares — an estimated $1.24M sold.

Weiss Multi-Strategy Advisers first reported a position in CMTA in Q3 2017 and held it in 6 quarters. The position peaked at $5.78M in Q3 2017. 48 funds tracked by Wall St. Rank hold CMTA as of Q1 2019.

Weiss Multi-Strategy Advisers reported no remaining Clementia Pharmaceuticals Inc. position as of Q1 2019 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 105,000 Clementia Pharmaceuticals Inc. shares in Q1 2019, an estimated $1.24M.
Weiss Multi-Strategy Advisers first reported a position in Clementia Pharmaceuticals Inc. in Q3 2017 and held it in 6 quarters.
Weiss Multi-Strategy Advisers's Clementia Pharmaceuticals Inc. position peaked at $5.78M in Q3 2017.
48 funds tracked by Wall St. Rank held Clementia Pharmaceuticals Inc. as of Q1 2019.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2019, filed 15 May 2019.